I agree and guessing that it's Japan. And that's the reason why:
"The review process [with Regience] is lengthy"
Plus
"but takes into account the spectacular growth in interest over the past 8 months or so in stem cell-based medicine in Japan".
That's sounds like they are confident to get more than just the small 25% premium attached to the 10 day VWAP as per LOI with Regience.
BUT... I let's keep and see and hopefully the is not another LOI waiting for us on Tuesday.
News: CYP Cynata Therapeutics announces trading halt, page-61
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29341 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 11015 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |